Last update 08 May 2025

Renaparin

Overview

Basic Info

Drug Type
Drug conjugates
Synonyms-
Target-
Action
modulators
Mechanism
Endothelial cell modulators
Therapeutic Areas
Other Diseases
Active Indication-
Inactive Indication
Delayed Graft Function
Originator Organization
Corline Biomedical ABCorline Biomedical AB
Active Organization-
Inactive Organization
Corline Biomedical ABCorline Biomedical AB
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

3
Clinical Trials associated with Renaparin
CTIS2022-501389-23-00
/ Not yet recruitingPhase 2
A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up. - RENAPAIR 02
CTIS2022-501389-23-02
/ Not yet recruitingPhase 2
A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up. - RENAPAIR 02
NCT03773211
/ CompletedPhase 1
Phase I Double Blind Placebo Controlled Safety Study of ex Vivo Treatment of Kidneys From Deceased Donors With Renaparin®, Followed by Transplantation to Study Population
100 Clinical Results associated with Renaparin
Login to view more data
100 Translational Medicine associated with Renaparin
Login to view more data
100 Patents (Medical) associated with Renaparin
Login to view more data
100 Deals associated with Renaparin
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Delayed Graft FunctionPhase 1
Sweden
Corline Biomedical ABCorline Biomedical AB
14 Feb 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free